What is the evidence for using hydroxyurea for secondary stroke prevention?

Jeffrey D. Lebensburger*, Michael R. DeBaun, Alexis A. Thompson

*Corresponding author for this work

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

A 10-year-old male patient with hemoglobin SS suffered a stroke at 7 years of age and was initially transfused at the time of presentation to lower the hemoglobin S concentration to < 30%. You are asked by the family if their child can be treated with oral hydroxyurea rather than monthly transfusions for the secondary prevention of strokes.

Fingerprint

Sickle Hemoglobin
Hydroxyurea
Secondary Prevention
Stroke

ASJC Scopus subject areas

  • Hematology

Cite this

@article{74d990481f204276a02d29466089843d,
title = "What is the evidence for using hydroxyurea for secondary stroke prevention?",
abstract = "A 10-year-old male patient with hemoglobin SS suffered a stroke at 7 years of age and was initially transfused at the time of presentation to lower the hemoglobin S concentration to < 30{\%}. You are asked by the family if their child can be treated with oral hydroxyurea rather than monthly transfusions for the secondary prevention of strokes.",
author = "Lebensburger, {Jeffrey D.} and DeBaun, {Michael R.} and Thompson, {Alexis A.}",
year = "2011",
doi = "10.1182/asheducation-2011.1.440",
language = "English (US)",
volume = "2011",
pages = "440--442",
journal = "Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program",
issn = "1520-4391",
publisher = "American Society of Hematology",

}

TY - JOUR

T1 - What is the evidence for using hydroxyurea for secondary stroke prevention?

AU - Lebensburger, Jeffrey D.

AU - DeBaun, Michael R.

AU - Thompson, Alexis A.

PY - 2011

Y1 - 2011

N2 - A 10-year-old male patient with hemoglobin SS suffered a stroke at 7 years of age and was initially transfused at the time of presentation to lower the hemoglobin S concentration to < 30%. You are asked by the family if their child can be treated with oral hydroxyurea rather than monthly transfusions for the secondary prevention of strokes.

AB - A 10-year-old male patient with hemoglobin SS suffered a stroke at 7 years of age and was initially transfused at the time of presentation to lower the hemoglobin S concentration to < 30%. You are asked by the family if their child can be treated with oral hydroxyurea rather than monthly transfusions for the secondary prevention of strokes.

UR - http://www.scopus.com/inward/record.url?scp=84859382036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859382036&partnerID=8YFLogxK

U2 - 10.1182/asheducation-2011.1.440

DO - 10.1182/asheducation-2011.1.440

M3 - Review article

C2 - 22160071

AN - SCOPUS:84859382036

VL - 2011

SP - 440

EP - 442

JO - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

JF - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

SN - 1520-4391

ER -